Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes.
Saved in:
| Title: | Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes. |
|---|---|
| Authors: | Hendriks DFG; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.; Hubrecht Institute, KNAW (Royal Netherlands Academy of Arts and Sciences), Utrecht, The Netherlands., Vorrink SU; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Smutny T; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Sim SC; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Nordling Å; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Ullah S; Division of Clinical Pharmacology, Karolinska University Hospital Laboratory, Stockholm, Sweden., Kumondai M; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.; Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan., Jones BC; DMPK, Oncology R&D, AstraZeneca, Cambridge, UK., Johansson I; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Andersson TB; DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lauschke VM; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden., Ingelman-Sundberg M; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden. |
| Source: | Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Oct; Vol. 108 (4), pp. 844-855. Date of Electronic Publication: 2020 May 22. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32320483 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hendriks+DFG%22">Hendriks DFG</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.; Hubrecht Institute, KNAW (Royal Netherlands Academy of Arts and Sciences), Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vorrink+SU%22">Vorrink SU</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Smutny+T%22">Smutny T</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Sim+SC%22">Sim SC</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Nordling+Å%22">Nordling Å</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ullah+S%22">Ullah S</searchLink>; Division of Clinical Pharmacology, Karolinska University Hospital Laboratory, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Kumondai+M%22">Kumondai M</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.; Laboratory of Pharmacotherapy of Life-Style Related Diseases, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.<br /><searchLink fieldCode="AU" term="%22Jones+BC%22">Jones BC</searchLink>; DMPK, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Johansson+I%22">Johansson I</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Andersson+TB%22">Andersson TB</searchLink>; DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Lauschke+VM%22">Lauschke VM</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ingelman-Sundberg+M%22">Ingelman-Sundberg M</searchLink>; Department of Physiology and Pharmacology, Section of Pharmacogenetics, Karolinska Institutet, Stockholm, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372741%22">Clinical pharmacology and therapeutics</searchLink> [Clin Pharmacol Ther] 2020 Oct; Vol. 108 (4), pp. 844-855. <i>Date of Electronic Publication: </i>2020 May 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0372741 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-6535 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099236%22">00099236 </searchLink><i>NLM ISO Abbreviation: </i>Clin Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32320483 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/cpt.1860 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 844 Titles: – TitleFull: Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hendriks DFG – PersonEntity: Name: NameFull: Vorrink SU – PersonEntity: Name: NameFull: Smutny T – PersonEntity: Name: NameFull: Sim SC – PersonEntity: Name: NameFull: Nordling Å – PersonEntity: Name: NameFull: Ullah S – PersonEntity: Name: NameFull: Kumondai M – PersonEntity: Name: NameFull: Jones BC – PersonEntity: Name: NameFull: Johansson I – PersonEntity: Name: NameFull: Andersson TB – PersonEntity: Name: NameFull: Lauschke VM – PersonEntity: Name: NameFull: Ingelman-Sundberg M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2020 Oct Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1532-6535 Numbering: – Type: volume Value: 108 – Type: issue Value: 4 Titles: – TitleFull: Clinical pharmacology and therapeutics Type: main |
| ResultId | 1 |